The Morning Read provides a 24-hour wrap up of everything else healthcare’s innovators need to know about the business of medicine (and beyond). The author of The Read published it but all full-time MedCity News journalists contribute to its content.
TOP STORIES
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
More Mark Cuban talking healthcare at SXSW: There’s plenty of space for disruption – and he’s stunned hospitals still fear the cloud.
We need more “physician champions.” Read this nice summary of a panel at the Summit on Healthcare Price Cost and Quality Transparency in Washington, D.C.
LIFE SCIENCE
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Olympus Medical sued again over LA superbug outbreak.
AstraZeneca’s chronic lung disease treatment has made it through its Phase III trials.
Nektar Therapeutics’s breast cancer treatment failed to move the needle in its late-stage study.
Biomet will stay on probation for yet another year.
Medical device lobbying: a little to Republicans, a little (less for Democrats). At least $4.5 million.
Swallowing Solutions has raised $1.1 million for its, well, swallowing solution.
Acute Myeloid Leukemia therapeutics market will reach $878.6 million by 2020.
The Coriell Institute for Medical Research was awarded a $14 million grant from the National Institute of General Medical Sciences.
The Camden research institute will use the funds from the five-year grant to support its NIGMS Human Genetic Cell Repository, which was established by the federal agency at Coriell in 1972. The repository houses a collection of more than 11,300 cell lines and 5,700 DNA samples that represent a variety of disease states, chromosomal abnormalities and healthy individuals.
A team of researchers in Cleveland and Peru has discovered that valacyclovir, a common drug used to treat the herpes virus, is effective in reducing HIV-1 levels, even when patients do not have herpes.
TECH
Great Lakes NeuroTechnologies has a new version of its continuous monitoring software for Parkinson’s patients: Kinesia 360.
Researchers from the University of North Carolina at Chapel Hill have sped up the process of 3D printing, producing objects in minutes instead of hours.
PAYERS-PROVIDERS
The New York Times went deep on Cleveland Clinic’s approach to healthcare. Among the notable lines:
The clinic cut expenses by roughly $500 million last year. The system is avoiding unnecessary lab tests, for example, and performing a hip replacement for $1,500 less than it did two years ago by standardizing the devices used and using less blood and other supplies, all, it says, without sacrificing quality. Its doctors are typically on salary, making it much easier for the clinic to work with them to figure out how to better care for patients.
Here’s what your patients will be asking about today: Diet soda increases your belly fat.
In-patient volume was down but revenue was up at Henry Ford Hospital, giving it a surplus in 2014.
Going beyond the Doc Fix, hospitals are hoping to get an extension on the way CMS pays for short hospital stays.
Blue Cross and Blue Shield of Illinois has formed four new accountable care organizations in the Chicago area.
A LITTLE EXTRA
All this powdered alcohol business seems pretty silly, but will it be successful, and is it even safe to consume?
[Photo from Flickr user Michael Flick]
